Royal Bank Of Canada Opiant Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.38 - $20.29 $309 - $669	-33 Reduced 2.68%	1,200 $24,000
Q3 2022 Nov 14, 2022	SELL	$9.52 - $13.48 $1,589 - $2,251	-167 Reduced 11.93%	1,233 $13,000
Q1 2022 May 16, 2022	BUY	$19.54 - $33.59 $3,908 - $6,718	200 Added 16.67%	1,400 $30,000
Q2 2021 Aug 16, 2021	BUY	$10.5 - $14.19 $12,600 - $17,028	1,200 New	1,200 $16,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.